Ai167 (TIT2L-ChrimsonR-tdT-ICL-tTA2) targeting vector Citations (1)

Originally described in: A Suite of Transgenic Driver and Reporter Mouse Lines with Enhanced Brain-Cell-Type Targeting and Functionality.
Daigle TL, Madisen L, Hage TA, Valley MT, Knoblich U, Larsen RS, Takeno MM, Huang L, Gu H, Larsen R, Mills M, Bosma-Moody A, Siverts LA, Walker M, Graybuck LT, Yao Z, Fong O, Nguyen TN, Garren E, Lenz GH, Chavarha M, Pendergraft J, Harrington J, Hirokawa KE, Harris JA, Nicovich PR, McGraw MJ, Ollerenshaw DR, Smith KA, Baker CA, Ting JT, Sunkin SM, Lecoq J, Lin MZ, Boyden ES, Murphy GJ, da Costa NM, Waters J, Li L, Tasic B, Zeng H Cell. 2018 Jul 12;174(2):465-480.e22. doi: 10.1016/j.cell.2018.06.035. PubMed Journal

---

Articles Citing Ai167 (TIT2L-ChrimsonR-tdT-ICL-tTA2) targeting vector

Articles
Epithelial barrier DUOX2 serves as early immune defense in intestinal pathogen control. O'Mara M, Zhang S, Fergus C, Kelly VP, Knaus UG. Mucosal Immunol. 2026 Jun;19(3):100343. doi: 10.1016/j.mucimm.2026.04.004. Epub 2026 Apr 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.